Kenneth J. Cavanaugh, Jr., PhD

Deputy Director, Office of Cardiovascular Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States

Presentation(s):

• FDA Japan: Sunday Session (Non-CME)

  Sunday, February 26, 2023
  8:00 AM – 12:00 PM ET

  Disclosure information not submitted.

• CDRH International Strategic Goals

  Sunday, February 26, 2023
  8:15 AM – 8:25 AM ET

  Disclosure information not submitted.

• Panel Discussion – How Can These Experiences Inform Future Global Clinical and Regulatory Strategies?

  Sunday, February 26, 2023
  9:30 AM – 10:15 AM ET

  Disclosure information not submitted.

• PRATICAL APPROACHES TO APPLYING REAL-WORLD CLINICAL EVIDENCE

  Sunday, February 26, 2023
  10:30 AM – 12:00 PM ET

  Disclosure information not submitted.

• Panel Discussion – What Specific Steps Can Be Taken to Facilitate Use of RWE Across Countries?

  Sunday, February 26, 2023
  11:10 AM – 11:50 AM ET

  Disclosure information not submitted.

• FDA Japan: Monday Session (Non-CME)

  Monday, February 27, 2023
  8:00 AM – 12:00 PM ET

  Disclosure information not submitted.